Psilocybin
Jennifer Chesak Writes About Psilocybin and Women – Podcast Episode #36
On this episode of the Psychedelic Invest Podcast, host Bruce Eckfeldt is joined by Jennifer Chesak, the author of The Psilocybin Handbook for Women. Jennifer…
On this episode of the Psychedelic Invest Podcast, host Bruce Eckfeldt is joined by Jennifer Chesak, the author of The Psilocybin Handbook for Women.
Jennifer is the author of the forthcoming book “Psilocybin for Women,” to be published by Ulysses Press and distributed by Simon & Schuster in 2023.
She is a Nashville-based freelance journalist, editor, fact-checker, and adjunct professor with more than two decades of experience. She earned her Master of Science in Journalism from Northwestern University’s Medill. Her writing has appeared in Washington Post, The Daily Beast, Healthline, Verywell, Greatist, Prevention, Runner’s World, Trail Runner, Women’s Running, Health, Better Homes and Gardens, Real Simple, and more. She also serves on Healthline’s Medical Integrity Team. In addition to editorial work, her cornucopia of clips showcases a robust lineup of content marketing for several global and national brands.
Teaching is also a passion for Jennifer. She is as an adjunct professor at Belmont University, where she teaches copyediting, nonfiction and technical editing, and media studies. In addition to mentoring students in Middle Tennessee State University’s certificate in writing program (MTSU Write), Jennifer is also the managing editor of the university’s literary magazine SHIFT. And she enjoys teaching evening and weekend workshops through Nashville’s literary nonprofit The Porch.
Stay tuned for more great Psychedelic Invest Podcast episodes… happening weekly.
If you just found out about the podcast, we encourage you to check out the Psychedelic Invest Podcast page or subscribe to the show on your favorite audio platform to binge and catch up.
The Transcription is Coming Soon
-
Psilocybin1 week ago
Psychedelic Underground Celebrated in San Francisco on Bicycle Day Weekend
-
Psychedelics6 days ago
Freedom Biosciences Announces FDA Approval of IND Application for FREE001 in Patients with Treatment-Resistant Depression
-
Law & Regulation5 days ago
Compass Pathways, Journey Clinical to develop psilocybin treatment delivery model
-
Psychedelics1 week ago
Compass Pathways and Journey Clinical Establish Research Collaboration Agreement To Inform the Training of Healthcare Providers and Delivery Model for COMP360 Psilocybin Treatment, If Approved for Treatment-Resistant Depression
-
Psychedelics1 week ago
Cybin to Participate at the 27th Annual Milken Institute Global Conference
-
Ketamine6 days ago
DEA poised to move cannabis to Schedule III
-
Psychedelics6 days ago
Behold! A New Mushroom Emoji Has Arrived!
-
Psychedelics6 days ago
Behold! A New Mushroom Emoji Has Arrived!